Sort
17,054 grants matching “genome editing”
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
$171,050Farshid Guilak · Washington University · R21 · FY2023 · AR
Administrative Core
$171,014Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Mechanisms of tamoxifen-associated endometrial cancer risk
$170,988Jason Gertz · University Of Utah · R21 · FY2024 · CA
IMPROVED TECHNOLOGIES FOR FULL LENGTH CDNA GENERATION
$170,941Mcgill University · R01 · FY2000 · CA
The Ubiquitin Editing Enzyme A20 Preserves Intestinal Epithelial Cell Homeostasis
$170,856Ling Shao · University Of Southern California · K08 · FY2017 · DK
Functional dissection of oncogenic enhancers
$170,856Daniel Herranz · Columbia University Health Sciences · K99 · FY2016 · CA
Functional dissection of oncogenic enhancers
$170,856Daniel Herranz · Columbia University Health Sciences · K99 · FY2015 · CA
Transgenic and Knockout Shared Resource
$170,818Darren Baker · Mayo Clinic Rochester · P30 · FY2025 · CA
Genetically Modified Mouse Core (GMMC)
$170,625Douglas J Epstein · University Of Pennsylvania · P30 · FY2025 · DK
Genetically Modified Mouse Core (GMMC)
$170,625Douglas J Epstein · University Of Pennsylvania · P30 · FY2024 · DK
Genetically Modified Mouse Core (GMMC)
$170,625Douglas J Epstein · University Of Pennsylvania · P30 · FY2023 · DK
Genetically Modified Mouse Core (GMMC)
$170,625Douglas J Epstein · University Of Pennsylvania · P30 · FY2022 · DK
Dissecting the role of clonal evolution in NPM1-mutant AML
$170,611Linde A Miles · Cincinnati Childrens Hosp Med Ctr · R00 · FY2024 · CA
Developing a Diurnal Rodent Model for Smith-Magenis Syndrome
$170,499Shigeki Iwase · University Of Michigan At Ann Arbor · R03 · FY2024 · NS
Engineering an HIV-resistant immune system for HIV cure
$170,446Hind Jawdat Fadel · Mayo Clinic Rochester · K08 · FY2016 · AI
Epigenetic Regulation of Mitochondiral Complex II
$170,432Gerald S Shadel · Yale University · R01 · FY2007 · CA
New computational, transcriptional, and genome editing approaches to the biology of inflammatory bowel disease
$170,260Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2018 · DK
Using Chromatin Architecture to Develop of Therapeutic Pipeline for Juvenile Arthritis
$170,186James N Jarvis · State University Of New York At Buffalo · R21 · FY2021 · AR
Novel molecular therapies for CPVT
$170,165Vassilios James Bezzerides · Boston Children'S Hospital · K08 · FY2021 · HL
Novel molecular therapies for CPVT
$170,165Vassilios James Bezzerides · Boston Children'S Hospital · K08 · FY2022 · HL
Novel molecular therapies for CPVT
$170,165Vassilios James Bezzerides · Boston Children'S Hospital · K08 · FY2020 · HL
Novel molecular therapies for CPVT
$170,165Vassilios James Bezzerides · Boston Children'S Hospital · K08 · FY2019 · HL
Novel molecular therapies for CPVT
$170,165Vassilios James Bezzerides · Boston Children'S Hospital · K08 · FY2018 · HL
Establishing Function of Understudied PRKCQ Kinase in Cellular Regulation and Disease
$170,000Alexandra C. Newton · University Of California, San Diego · R03 · FY2019 · TR
Rat Germline Gene Editing Products and Services
$169,997F. Kent Hamra · Genomedesigns Laboratory, Llc · R43 · FY2017 · DA